Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON22766Recruiting
Open-label trial of atorvastatin in atherosclerosis (2 arms), sponsored by Netherlands Heart Institute. Primary endpoint: Change in carotid intima-media thickness. Started Sep 2007; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON22766.